Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function (Q40994004)

25 September 2017

title

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function (English)

1 reference

25 September 2017

1 reference

Fischer K

1

1 reference

25 September 2017

Lutz V

2

1 reference

25 September 2017

Wilhelm O

3

1 reference

25 September 2017

Schmitt M

4

1 reference

25 September 2017

Graeff H

5

1 reference

25 September 2017

Heiss P

6

1 reference

25 September 2017

Nishiguchi T

7

1 reference

25 September 2017

Harbeck N

8

1 reference

25 September 2017

Kessler H

9

1 reference

25 September 2017

Luther T

10

1 reference

25 September 2017

Magdolen V

11

1 reference

25 September 2017

Reuning U

12

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

25 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

25 September 2017

volume

438

1 reference

25 September 2017

issue

1-2

1 reference

25 September 2017

page(s)

101-105

1 reference

Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Blockage of the urokinase receptor on the cell surface: construction and characterization of a hybrid protein consisting of the N-terminal fragment of human urokinase and human albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase‐induced tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Growth factor-like effect of urokinase type plasminogen activator in human renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

In vitro anti-proliferative and anti-invasive role of aminoterminal fragment of urokinase-type plasminogen activator on 8701-BC breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901279-4

10.1016/S0014-5793(98)01279-4

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference